GetTopicDetailResponse(id=b67712628680, topicName=莫洛利單抗, introduction=, content=AML 阿扎胞苷 維奈托克 莫洛利單抗, image=null, comments=0, allHits=278, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Wed Apr 23 14:31:00 CST 2025, time=2025-04-23, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=503714, tagList=[TagDto(tagId=503714, tagName=莫洛利單抗)], ipAttribution=, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2261711, encodeId=420c2261e1121, content=<a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a> <a href='/topic/show?id=96129e81891' target=_blank style='color:#2F92EE;'>#阿扎胞苷#</a> <a href='/topic/show?id=1115e90262d' target=_blank style='color:#2F92EE;'>#維奈托克#</a> <a href='/topic/show?id=b67712628680' target=_blank style='color:#2F92EE;'>#莫洛利單抗#</a>, objectTitle=Blood | ENHANCE-3試驗(yàn)：維奈托克和阿扎胞苷聯(lián)合莫洛利單抗或安慰劑治療不適合強(qiáng)化治療的急性髓系白血病（AML）, objectType=article, longId=872907, objectId=af6c8e290740, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240702/1719884874961_92910.jpg, objectUrl=/article/show_article.do?id=af6c8e290740, replyNumber=0, likeNumber=42, createdTime=2025-04-23, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af6c8e290740, moduleTitle=Blood | ENHANCE-3試驗(yàn)：維奈托克和阿扎胞苷聯(lián)合莫洛利單抗或安慰劑治療不適合強(qiáng)化治療的急性髓系白血?。ˋML）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=af6c8e290740)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-04-23
